Efficacy News and Research

RSS
Inclusion of VR technology in cognitive rehabilitation research and care for multiple sclerosis

Inclusion of VR technology in cognitive rehabilitation research and care for multiple sclerosis

CDC recommends a second safe, effective COVID-19 vaccine for children 6 through 17 years of age

CDC recommends a second safe, effective COVID-19 vaccine for children 6 through 17 years of age

Age-specific susceptibility during the Omicron driven, Delta driven, and pre-Delta waves in South Korea

Age-specific susceptibility during the Omicron driven, Delta driven, and pre-Delta waves in South Korea

Effectiveness of Pfizer-BioNTech’s BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron variants among teens

Effectiveness of Pfizer-BioNTech’s BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron variants among teens

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

Study finds Omicron variant could break through vaccine protection more effectively than the Delta variant

Study finds Omicron variant could break through vaccine protection more effectively than the Delta variant

Memory B cells can be localized in the lungs, research shows

Memory B cells can be localized in the lungs, research shows

Study compares protection induced by Delta breakthrough infections vs. COVID boosters against Omicron

Study compares protection induced by Delta breakthrough infections vs. COVID boosters against Omicron

Subgroups of preterm born children can be distinguished with distinct outcome profiles, study reports

Subgroups of preterm born children can be distinguished with distinct outcome profiles, study reports

Researchers assess the evidence basis for medications used to treat spine-related pain in older adults

Researchers assess the evidence basis for medications used to treat spine-related pain in older adults

Low rates of severe COVID-19 found in patients treated with monoclonal antibodies during delta surge

Low rates of severe COVID-19 found in patients treated with monoclonal antibodies during delta surge

Effectiveness of monoclonal antibodies and directly acting antivirals against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages

Effectiveness of monoclonal antibodies and directly acting antivirals against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages

Cell-based assay highlights differences in antibody neutralizing capacity for SARS-CoV-2 variants

Cell-based assay highlights differences in antibody neutralizing capacity for SARS-CoV-2 variants

A cancer patient who had SARS-CoV-2 for over eight months

A cancer patient who had SARS-CoV-2 for over eight months

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

In 1st year of pandemic, COVID vaccines saved 20M lives

In 1st year of pandemic, COVID vaccines saved 20M lives

Innovative treatment reduces post-traumatic headache related disability, study finds

Innovative treatment reduces post-traumatic headache related disability, study finds

Researchers investigate clinical epidemiological impact of Omicron among hospitalized COVID-19 patients

Researchers investigate clinical epidemiological impact of Omicron among hospitalized COVID-19 patients

Breakthrough infection with pre-Omicron variant induces cross-neutralizing activity against Omicron

Breakthrough infection with pre-Omicron variant induces cross-neutralizing activity against Omicron

Chemically modified rocaglates have a stronger effect against viral replication

Chemically modified rocaglates have a stronger effect against viral replication

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.